Skeletal Disorder TRIZ Cases

Self-assembling collagen matrices bind growth factors to hydroxyapatite surfaces, preventing rapid migration and maintaining osteoinductive efficacy.

Particulate articular cartilage composition promotes rapid defect coverage while preserving native tissue properties.

HU-671 fatty acid amides inhibit osteoclast activity to restore bone volume and reduce fracture risk in Prader-Willi syndrome.

Mesenchymal stem cells proliferate in a defined serum-free medium containing specific growth factors and lipids.

Functionalized dendrimers selectively target immunosuppressive cells, resolving poor clinical outcomes from non-specific immune modulation.

A titanium oxide surface layer on a titanium substrate promotes apatite formation through controlled surface irregularities and positive zeta potential.

Segmentation by CD107a expression separates progenitors to resolve the contradiction between treatment potential and differentiation control.

Daily oral dried garlic supplement reduces inflammatory cytokine concentration and cartilage degradation enzyme levels in knee osteoarthritis patients.

Measure MMP-1, MMP-3, and 14-3-3 proteins via ELISA assays to resolve treatment specificity limits.

Comminuted natural zeolite with optimized particle size distribution enhances bone density through targeted ion exchange mechanisms.

Lactobacillus plantarum TWK10 addresses sarcopenia by improving muscle strength and walking capacity despite age-related physiological variability.

Monoclonal antibodies bind ACVR1 to inhibit BMP signaling, reducing heterotopic ossification in fibroplasia ossificans progressiva.

Anti-IL-20 antibody treatment suppresses cancer-induced bone loss by blocking IL-20 signaling pathways.

Anemoside B4 reduces joint swelling in acute gouty arthritis without the severe side effects of conventional anti-inflammatory drugs.

A tri-component matrix of type II collagen, hyaluronan, and chondroitin sulfate supports chondrocyte implantation.

Selective EP4 receptor antagonists inhibit cartilage destruction and promote calcification in explant models.

Distinct plasma metabolite signatures classify rheumatoid arthritis disease activity status through targeted biomarker analysis.

Botanical formulation with specific herbal ratios treats thermal injuries complicated by bone damage, promoting tissue restoration.

Substituted acrylonitrile derivatives block Noggin to potentiate BMP activity, reducing required doses and donor site complications.

Iterative freeze-drying creates a multi-layer collagen scaffold that mimics osteochondral morphology while eliminating donor site morbidity.

A composite composition of pomegranate, eucommia bark, and achyranthis radix extracts regenerates articular cartilage.

Direct peptide conjugation simplifies manufacturing while enhancing selectivity and reducing toxicity on normal tissues.

A fibrosis-inducing medication restores intervertebral disc height and biomechanical properties through controlled tissue formation.

Antibodies block the Notum enzyme inhibitor to activate WNT signaling, resolving limited bone formation from antiresorptive agents.

Cabozantinib reduces bone resorption markers while increasing bone formation markers to improve bone mineral density.

Naphthoquinone compounds treat osteoporosis by inhibiting bone loss while avoiding oesophagitis risks.

Alcohol extraction of Pennisetum yields an extract that inhibits osteoclast differentiation.

Truncated C4BP polypeptides induce tolerogenic states via CCP6 domains, reducing toxicity and improving survival in lupus models.

A composite treatment solution combines water-soluble polymers with phosphatidylcholine liposomes to modify contact lens surfaces.

A composition combining unsaponifiable fractions with krill oil promotes extracellular matrix synthesis and tissue repair.

Encasing acellular tissue matrix in polymer reduces immunological response while maintaining structural stability for tissue repair.

Alkyl-modified theobromine interferes with uric acid supersaturation by increasing induction time and altering crystal morphology to prevent stone formation.

A tertiary culture method using FGF-2, TGFβ, and heparin enhances the production of MSC-derived chondro-osteoblastic cells.

Chemically crosslinked polyorganophosphazenes form stronger gel structures via UV irradiation, resolving low solidity in injectable biomaterials.

Trolox scavenges free radicals generated by DMSO to prevent oxidative damage and maintain cell viability.

Encapsulating adipose-derived stem cells in a biocompatible hydrogel matrix maintains cellular viability and metabolic function.

Segmenting mineralized and demineralized bone allows independent optimization of calcium content and handling characteristics for reliable fusion.

Supercritical CO2 extraction yields standardized extracts that lower NIH-CPSI scores by addressing insufficient efficacy of single components.

Unique CDR sequences in monoclonal antibodies resolve binding specificity contradictions for CEACAM1 and related subtypes.

CR2 binding proteins block antigen retention mechanisms, reducing autoantibody production and viral persistence in autoimmune conditions.

TGF-beta enhancing compounds promote cellular proliferation to delay osteoarthritis progression.

Poly(caprolactone fumarate) copolymerizes with fumaric acid to form self-crosslinkable biomaterials for injectable tissue regeneration.

Subcutaneous local anesthetic composition blocks neural transmission at the inguinal region to relieve pelvic girdle pain.

Electrophoresis isolates viable chondrocytes from cartilage tissue fragments, eliminating multi-step surgeries and cell de-differentiation.

Alpinia oxyphylla extract lowers blood uric acid concentrations through enzymatic inhibition.

Selected mesenchymal stem cells with IPBv > 170 treat arthritis without drug side effects.

Combines endothelial progenitor cells and mesenchymal stem cells with a collagenous extracellular matrix to promote new bone growth.

HICA targets ADAMTS-5 and MMP-13 to stop cartilage erosion, addressing inadequate current osteoarthritis treatments.

Eucommia ulmoides extract composition strengthens bone density through synergistic herbal ratios.

Heavy chain-only antibodies bind CD22 with high affinity, resolving inconsistent clinical efficacy of standard monoclonal therapies.